Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the detailed record of transactions filed by Kaye Edward M. MD, Consejero. Director active across 5 companies, notably Cytokinetics INC. Aggregated, 63 reports have been logged. Split: 0 buy · 15 sells. Total volume traded: €3.6m. History available since 12 May 2021. The latest transaction was disclosed on 14 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Kaye Edward M. MD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
328 títulos@ 38,01 US$8.7% de su flujoCommon StockSEC:0001127602-25-019288:0
25 de 63 declaraciones
About Kaye Edward M. MD
Kaye Edward M. MD is Administrateur. He has filed 59 filings in total, and in the sampled recent filings the transactions run from 2016-01-25 to 2026-06-01, with EUR 0 of buys and EUR 3266448 of sales. The largest recent filings concern Stoke Therapeutics, Inc. and CYTOKINETICS INC.